Histórico Etiquetas: vaccine

The epidemiological situation in Spain shows us a complex picture. We are facing a fifth wave of the pandemic that differs significantly from the previous ones in which the National Vaccination Strategy against COVID-19 advances positively, but the cumulative incidence at 14 days per 100,000 inhabitants continues to skyrocket. The reason is found in ...

This Wednesday, the US pharmaceutical Pfizer has presented new data from its own study that suggests that a third dose of the vaccine against Covid-19 can «strongly» boost protection against the delta variant, compared to the two-dose scheme. The preliminary study, and which has not been subjected to peer review, shows that with a third dose ...

The Committee for Human Medicines (CHMP) of the European Medicines Agency (EMA) has recommended granting an extension for the vaccine against COVID-19 Spikevax (formerly known as COVID- 19 Vaccine Moderna) to include use in young people aged 12-17 years . The vaccine was already authorized in people over 18 years of age. The use of ...

Each and every one of the COVID-19 vaccines currently being inoculated in the European Union have proven their efficacy and safety. This has been confirmed by the exhaustive evaluations carried out by the European Medicines Agency (EMA, for its acronym in English), based on the documentation required of the manufacturers collected from the ...

The Israeli Ministry of Health has published a study indicating that the effectiveness of the Pfizer-BioNTech vaccine against COVID-19 does not protect as much against the Delta variant as had been confirmed at first. While research by Public Health Egnland (PHE) had found that the Pfizer vaccine prevented 96% of hospitalizations and 88% the development of ...